Pulmonary delivery of cationic gold nanoparticles boost antigen-specific CD4+ T Cell Proliferation

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 7, 2016, Pages 1815-1826

  Seydoux, Emilie ^a,c   Rodriguez Lorenzo, Laura ^b   Blom, Rebecca A M ^a,c   Stumbles, Philip A ^d,e   Petri Fink, Alke ^b   Rothen Rutishauser, Barbara ^b   Blank, Fabian ^a   von Garnier, Christophe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d MURDOCH UNIVERSITY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Dendritic cell; Gold nanoparticles; Immune modulation; Macrophage; Respiratory tract

Indexed keywords

ANTIGENS; BIOLOGICAL ORGANS; CELL CULTURE; CELL PROLIFERATION; CELLS; CYTOLOGY; FIBER OPTIC SENSORS; GOLD; MACROPHAGES; METAL NANOPARTICLES; NANOPARTICLES;

ANTIGEN PRESENTING CELLS; CATIONIC GOLD NANOPARTICLES; CHARGED FUNCTIONAL GROUPS; DENDRITIC CELLS; GOLD NANOPARTICLES; IMMUNE MODULATION; PULMONARY DELIVERY; RESPIRATORY TRACT;

T-CELLS;

CD11B ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GOLD NANOPARTICLE; OVALBUMIN; GOLD; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BIOCOMPATIBILITY; CD4+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HYDRODYNAMICS; IMMUNE RESPONSE; IMMUNOMODULATION; INTRANASAL DRUG ADMINISTRATION; LUNG PARENCHYMA; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; SURFACE CHARGE; UPREGULATION; ZETA POTENTIAL; ANIMAL; CELL PROLIFERATION; LUNG; LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GOLD; LUNG; LYMPHOCYTE ACTIVATION; MICE; NANOPARTICLES;

EID: 84973469425     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2016.02.020     Document Type: Article

References (50)

1. Patton J.S., Byron P.R. Inhaling medicines: Delivering drugs to the body through the lungs. Nat Rev 2007, 6(1):67-74.
2. Csaba N., Garcia-Fuentes M., Alonso M.J. Nanoparticles for nasal vaccination. Adv Drug Deliv Rev 2009, 61(2):140-157.
3. Joshi M.D., Unger W.J., Storm G., van Kooyk Y., Mastrobattista E. Targeting tumor antigens to dendritic cells using particulate carriers. J Control Release 2012, 161(1):25-37.
4. Kunda N.K., Somavarapu S., Gordon S.B., Hutcheon G.A., Saleem I.Y. Nanocarriers targeting dendritic cells for pulmonary vaccine delivery. Pharm Res 2013, 30(2):325-341.
5. Paulis L.E., Mandal S., Kreutz M., Figdor C.G. Dendritic cell-based nanovaccines for cancer immunotherapy. Curr Opin Immunol 2013, 25:1-7.
6. Sung J., Pulliam B., Edwards D. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 2007, 25(12):563-570.
7. Ross K.A., Haughney S.L., Petersen L.K., Boggiatto P., Wannemuehler M.J., Narasimhan B. Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours. Adv Healthc Mater 2014, 3(7):1071-1077.
8. Li A.V., Moon J.J., Abraham W., Suh H, Elkhader J, Seidman M.A., et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med 2013, 5(204):204ra130.
9. Mann J.F.S., McKay P.F., Arokiasamy S., Patel R.K., Klein K., Shattock R.J. Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection. J Control Release 2013, 170(3):452-459.
10. Nembrini C., Stano A., Dane K.Y., Ballester M, van der Vlies A.J., Marsland B.J., et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. PNAS 2011, 108(44):E989-E997.
11. Blank F., Stumbles P., von Garnier C. Opportunities and challenges of the pulmonary route for vaccination. Expert Opin Drug Deliv 2011, 8(5):547-563.
12. Taratula O., Kuzmov A., Shah M., Garbuzenko O., Minko T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release 2013, 171(3):349-357.
13. Blank F., Stumbles P.A., Seydoux E., Holt P.G, Fink A., Rothen Rutishauser B., et al. Size-dependent uptake of particles by pulmonary APC populations and trafficking to regional lymph nodes. Am J Respir Cell Mol Biol 2013, 49:67-77.
14. Blank F., Gerber P., Rothen Rutishauser B., Skulkhu U., Salaklang J., de Peyer K., et al. Biomedical nanoparticles modulate specific CD4(+) T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology 2011, 5:606-621.
15. Hardy C.L., LeMasurier J.S., Belz G.T., Scalzo-Inquanti K., Yao J., Xiang S.D., et al. Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. J Immunol 2012, 188(3):1431-1441.
16. Rodriguez-Lorenzo L., Fytianos K., Blank F., von Garnier C., Rothen-Rutishauser B., Petri-Fink A. Fluorescence-encoded gold nanoparticles: Library design and modulation of cellular uptake into dendritic cells. Small 2014, 1-10.
17. Enüstün B., Turkevich J. Coagulation of colloidal gold. J Am Chem Soc 1963, 85(21).
18. Fytianos K., Rodriguez-Lorenzo L., Clift M.J.D., Blank F., Vanhecke D., von Garnier C., et al. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine 2015, 11(3):633-644.
19. Von Garnier C., Filgueira L., Wikstrom M., Smith M., Thomas J.A., Strickland D.H., et al. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J Immunol 2005, 175(3):1609-1618.
20. Seydoux E., Rothen-Rutishauser B., Nita I.M., Balog S., Gazdhar A., Stumbles P.A., et al. Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation. Int J Nanomedicine 2014, 9:3885-3902.
21. Sperling R.A., Rivera Gil P., Zhang F., Zanella M., Parak W.J. Biological applications of gold nanoparticles. Chem Soc Rev 2008, 37:1896-1908.
22. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60(11):1307-1315.
23. Almeida J.P.M., Figueroa E.R., Drezek R.A. Gold nanoparticle mediated cancer immunotherapy. Nanomedicine 2014, 10(3):503-514.
24. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8(12):958-969.
25. Xue J., Schmidt S.V., Sander J., Draffehn A., Krebs W., Quester I., et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014, 40(2):274-288.
26. Robbe P., Draijer C., Borg T.R., Luinge M., Timens W., Wouters I.M., et al. Distinct macrophage phenotypes in allergic and nonallergic lung inflammation. Am J Physiol Lung Cell Mol Physiol 2015, 308(4):L358-L367.
27. Hussell T., Bell T.J. Alveolar macrophages: Plasticity in a tissue-specific context. Nat Rev Immunol 2014, 14(2):81-93.
28. Kirby A.C., Coles M.C., Kaye P.M. Alveolar macrophages transport pathogens to lung draining lymph nodes. J Immunol 2009, 183(3):1983-1989.
29. Geiser M., Quaile O., Wenk A., Wigge C., Eigeldinger-Berthou S., Him S., et al. Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol 2013, 10:1-10.
30. Brandenberger C., Rothen-Rutishauser B., Mühlfeld C., Schmid O., Ferron G.A., Maier K.L., et al. Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicol Appl Pharmacol 2010, 242(1):56-65.
31. Harush-Frenkel O., Rozentur E., Benita S., Altschuler Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 2008, 9(2):435-443.
32. Marquis B.J., Liu Z., Braun K.L., Haynes C.L. Investigation of noble metal nanoparticle ζ-potential effects on single-cell exocytosis function in vitro with carbon-fiber microelectrode amperometry. Analyst 2011, 136(17):3478-3486.
33. Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 2012, 7:5577-5591.
34. Hirsch V., Kinnear C., Moniatte M., Rothen-Rutishauser B., Clift M.J.D., Fink A. Surface charge of polymer coated SPIONs influences the serum protein adsorption, colloidal stability and subsequent cell interaction in vitro. Nanoscale 2013, 5(9):3723-3732.
35. Fromen C.A., Rahhal T.B., Robbins G.R., Kai M.P., Shen T.W., Luft J.C., et al. Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells. Nanomedicine 2016, 12(3):677-687.
36. Gieseler R.K., Marquitan G., Hahn M.J., Perdon L.A., Driessen W.H., Sullivan S.M., et al. DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: Implications for HIV disease. Scand J Immunol 2004, 59(5):415-424.
37. van Broekhoven C.L., Parish C.R., Demangel C., Britton W.J., Altin J.G. Targeting dendritic cells with antigen-containing liposomes: A highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res 2004, 64:4357-4365.
38. Jakubzick C., Tacke F., Llodra J., van Rooijen N., Randolph G.J. Modulation of dendritic cell trafficking to and from the airways. J Immunol 2006, 176(6):3578-3584.
39. Hardy C.L., Lemasurier J.S., Mohamud R., Yao J., Xiang S.D., Rolland J.M., et al. Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints. J Immunol 2013, 191(10):5278-5290.
40. Von Garnier C., Wikstrom M.E., Zosky G., Turner D.J., Sly P.D., Smith M., et al. Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. J Immunol 2007, 179(9):5748-5759.
41. Thornton E.E., Looney M.R., Bose O., Sen D., Sheppard D., Locksley R., et al. Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung. J Exp Med 2012, 209(6):1183-1199.
42. Wikstrom M.E., Stumbles P.A. Mouse respiratory tract dendritic cell subsets and the immunological fate of inhaled antigens. Immunol Cell Biol 2007, 85(3):182-188.
43. Von Garnier C., Nicod L.P. Immunology taught by lung dendritic cells. Swiss Med Wkly 2009, 139(13-14):186-192.
44. Holt P.G., Strickland D.H., Wikström M.E., Jahnsen F.L. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008, 8(2):142-152.
45. Wikstrom M.E., Batanero E., Smith M., Thomas J.A., von Garnier C., Holt P.G., et al. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen. J Immunol 2006, 177(2):913-924.
46. Choi H.S., Ashitate Y., Lee J.H., Kim S.H., Matsui A., Insin N., et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 2010, 28(12):1300-1303.
47. Lehmann A.D., Parak W.J., Zhang F., Ali Z., Röcker C., Nienhaus G.U., et al. Fluorescent-magnetic hybrid nanoparticles induce a dose-dependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small 2010, 6(6):753-762.
48. Fröhlich E. Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo. Int J Nanomedicine 2015, 10:3761-3778.
49. van der Maaden K., Yu H., Sliedregt K., Zwier R., Leboux R., Oguri M., et al. Nanolayered chemical modification of silicon surfaces with ionizable surface groups for pH-triggered protein adsorption and release: Application to microneedles. J Mater Chem. B. 2013, 1:4466-4477.
50. Belz G.T., Smith C.M., Kleinert L., Reading P., Brooks A., Shortman K., et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. PNAS 2004, 101(23):1-6.